These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 37017872
1. New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications. Luna DE, Shinohara MM. Curr Hematol Malig Rep; 2023 Jun; 18(3):83-88. PubMed ID: 37017872 [Abstract] [Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [Abstract] [Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [Abstract] [Full Text] [Related]
4. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma. Mehdi SJ, Moerman-Herzog A, Wong HK. BMC Cancer; 2021 May 03; 21(1):492. PubMed ID: 33941102 [Abstract] [Full Text] [Related]
5. Novel therapeutic approaches for cutaneous T cell lymphomas. Pavlidis A, Piperi C, Papadavid E. Expert Rev Clin Immunol; 2021 Jun 03; 17(6):629-641. PubMed ID: 33890833 [Abstract] [Full Text] [Related]
6. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside. Damsky WE, Choi J. Curr Treat Options Oncol; 2016 Jul 03; 17(7):33. PubMed ID: 27262707 [Abstract] [Full Text] [Related]
7. Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma. Licht P, Mailänder V. Cells; 2022 Jan 19; 11(3):. PubMed ID: 35159138 [Abstract] [Full Text] [Related]
8. Mapping signal transducer and activator of transcription (STAT) activity in different stages of mycosis fungoides and Sezary syndrome. Olszewska B, Żawrocki A, Lakomy J, Karczewska J, Gleń J, Zabłotna M, Malek M, Jankau J, Lange M, Biernat W, Nowicki RJ, Sokołowska-Wojdyło M. Int J Dermatol; 2020 Sep 19; 59(9):1106-1112. PubMed ID: 32643174 [Abstract] [Full Text] [Related]
9. Tumor microenvironment in mycosis fungoides and Sézary syndrome. Rubio Gonzalez B, Zain J, Rosen ST, Querfeld C. Curr Opin Oncol; 2016 Jan 19; 28(1):88-96. PubMed ID: 26632770 [Abstract] [Full Text] [Related]
10. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Wong HK, Mishra A, Hake T, Porcu P. Br J Haematol; 2011 Oct 19; 155(2):150-66. PubMed ID: 21883142 [Abstract] [Full Text] [Related]
11. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome. Kawana Y, Suga H, Kamijo H, Miyagaki T, Sugaya M, Sato S. Int J Mol Sci; 2021 Nov 22; 22(22):. PubMed ID: 34830466 [Abstract] [Full Text] [Related]
12. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. Patil K, Kuttikrishnan S, Khan AQ, Ahmad F, Alam M, Buddenkotte J, Ahmad A, Steinhoff M, Uddin S. Semin Cancer Biol; 2022 Nov 22; 86(Pt 3):382-399. PubMed ID: 34906723 [Abstract] [Full Text] [Related]
13. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma. Sakamoto M, Miyagaki T, Kamijo H, Oka T, Boki H, Takahashi-Shishido N, Suga H, Sugaya M, Sato S. Int J Mol Sci; 2021 Jul 23; 22(15):. PubMed ID: 34360654 [Abstract] [Full Text] [Related]
14. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome. Sethi TK, Montanari F, Foss F, Reddy N. Br J Haematol; 2021 Nov 23; 195(3):352-364. PubMed ID: 33987825 [Abstract] [Full Text] [Related]
15. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma. Gill RPK, Gantchev J, Martínez Villarreal A, Ramchatesingh B, Netchiporouk E, Akilov OE, Ødum N, Gniadecki R, Koralov SB, Litvinov IV. Cells; 2022 Feb 09; 11(4):. PubMed ID: 35203244 [Abstract] [Full Text] [Related]
16. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Guglielmo A, Zengarini C, Agostinelli C, Motta G, Sabattini E, Pileri A. Cells; 2024 Mar 28; 13(7):. PubMed ID: 38607023 [Abstract] [Full Text] [Related]
17. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E. Dermatology; 2005 Mar 28; 211(2):84-92. PubMed ID: 16088151 [Abstract] [Full Text] [Related]
18. The Microenvironment's Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications. Pileri A, Guglielmo A, Grandi V, Violetti SA, Fanoni D, Fava P, Agostinelli C, Berti E, Quaglino P, Pimpinelli N. Cells; 2021 Oct 17; 10(10):. PubMed ID: 34685762 [Abstract] [Full Text] [Related]
19. The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome. Liu Z, Wu X, Hwang ST, Liu J. Ann Dermatol; 2021 Dec 17; 33(6):487-496. PubMed ID: 34858000 [Abstract] [Full Text] [Related]
20. Sézary syndrome originates from heavily mutated hematopoietic progenitors. Harro CM, Sprenger KB, Chaurio RA, Powers JJ, Innamarato P, Anadon CM, Zhang Y, Biswas S, Mandal G, Mine JA, Cortina C, Nagy MZ, Martin AL, Handley KF, Borjas GJ, Chen PL, Pinilla-Ibarz J, Sokol L, Yu X, Conejo-Garcia JR. Blood Adv; 2023 Sep 26; 7(18):5586-5602. PubMed ID: 37531660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]